You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Indian Covid vaccines better than Pfizer, Moderna says Adar Poonawalla

Covid vaccines

Topics
Coronavirus Vaccine | Coronavirus | Pfizer

ANI 

Adar Poonawalla, chief executive officer (CEO) of Serum Institute of India
Adar Poonawalla, chief executive officer (CEO) of Serum Institute of India (Photo: PTI image)

 

New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that "Made in India" COVID-19 vaccines have provided more protection against the infection than mRNA vaccines like and Moderna.

Speaking to ANI, the SII CEO said, "The COVID-19 vaccines which have been made in India are providing more protection against the disease than mRNA vaccines like and Moderna."

"It's good that vaccines like and Moderna are not introduced in India, because in countries like US people have taken 2nd and 3rd booster dose and still many are getting infected with Corona but in India, our vaccines have given good protection," Poonawala stated.

On being asked about the export of the Covishield COVID-19 vaccine, the SII CEO informed that India has exported it to more than 80 countries so far.

"We have exported Covishield to more than 80 countries and 10 crore doses so far. Now, the demand for COVID vaccine has been reduced due to declining cases," he added.

He also added that "In some countries where mRNA vaccine was given, many people were hospitalised and cases were reported in those countries because they were not providing good protection against the viral infection.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, April 13 2022. 15:03 IST
RECOMMENDED FOR YOU